跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,895 条关于
“epNETs”
全部
1,895
临床试验
1,786
药物
0
机构
0
资讯
109
2年前
Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors
2年前
Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors
2年前
Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors
2年前
Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors
去年
Cabozantinib Significantly Improves Progression-Free Survival in Advanced Neuroendocrine Tumors
11个月前
ITM to Present Phase 3 COMPETE Trial Subgroup Analyses at NANETS 2025, Highlighting 177Lu-edotreotide Success in GEP-NETs
4年前
China NMPA Accepts NDA for ORPATHYS® and TAGRISSO® Combination in NSCLC with MET Amplification
去年
FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer
去年
Aviceda Therapeutics Completes Enrollment in Phase 2b SIGLEC Study of AVD-104 for Geographic Atrophy
去年
Belzutifan Approved in China for VHL-Associated Tumors
第 1 页,共 11 页
上一页
下一页